Access to Care
Priority Issues
Ensuring patients have access to the highest quality patient-centered care is central to the AAN's mission. The AAN supports affordable access to telehealth services and prescription medications as part of this priority.
Drug Costs and access
Prescription drug prices continue to rise. Drugs that treat complex, chronic conditions like Alzheimer's disease, Parkinson’s disease, epilepsy, and migraine, and specialty drugs that require special handling or administration, such as those used for multiple sclerosis, are particularly expensive.
The AAN supports: Action to ensure that prescription medications are accessible for patients with complex, chronic neurologic conditions; and potential solutions which may include price negotiation and transparency.
Additional Resources:
View Prescription Drug Prices Position Statement
Access Monoclonal Antibodies for Alzheimer's Resources
Summary of the Key Health Care Provisions of the Inflation Reduction Act of 2022
Recent Activity:
Telehealth
The AAN believes that telehealth will continue to play an essential role in the care of patients with neurologic conditions. The AAN supports coverage of telehealth services regardless of patient location, equitable provider reimbursement, simplified state licensing requirements, and expanded telehealth research and quality initiatives.
Additional Resources:
Access Telehealth Practice Resources
View Telehealth Position Statement
Recent Activity
- AAN Comments on Drug Enforcement Agency's Proposed Rule for Telehealth Prescribing | Posted March 22, 2023
- AAN Joins Call to Harmonize Deadlines Impacting Medicare Telehealth | Posted January 26, 2023
- AAN Provides Input for Updated CONNECT for Health Act | Posted January 26, 2023
- AAN Calls on CMS to Add Services to the Medicare Telehealth List | Posted January 25, 2023